PMID- 20061396 OWN - NLM STAT- MEDLINE DCOM- 20100429 LR - 20211020 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 285 IP - 10 DP - 2010 Mar 5 TI - Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation. PG - 6891-903 LID - 10.1074/jbc.M109.078428 [doi] AB - Here, a group of specific lipids, comprising phosphatidylethanolamine (PE)- or phosphatidylcholine (PC)-esterified 12S-hydroxyeicosatetraenoic acid (12S-HETE), generated by 12-lipoxygenase was identified and characterized. 12S-HETE-PE/PCs were formed within 5 min of activation by thrombin, ionophore, or collagen. Esterified HETE levels generated in response to thrombin were 5.85 +/- 1.42 (PE) or 18.35 +/- 4.61 (PC), whereas free was 65.5 +/- 17.6 ng/4 x 10(7) cells (n = 5 separate donors, mean +/- S.E.). Their generation was stimulated by triggering protease-activated receptors-1 and -4 and signaling via Ca(2+) mobilization secretory phospholipase A2, platelet-activating factor-acetylhydrolase, src tyrosine kinases, and protein kinase C. Stable isotope labeling showed that they form predominantly by esterification that occurs on the same time scale as free acid generation. Unlike free 12S-HETE that is secreted, esterified HETEs remain cell-associated, with HETE-PEs migrating to the outside of the plasma membrane. 12-Lipoxygenase inhibition attenuated externalization of native PE and phosphatidylserine and HETE-PEs. Platelets from a patient with the bleeding disorder, Scott syndrome, did not externalize HETE-PEs, and liposomes supplemented with HETE-PC dose-dependently enhanced tissue factor-dependent thrombin generation in vitro. This suggests a role for these novel lipids in promoting coagulation. Thus, oxidized phospholipids form by receptor/agonist mechanisms, not merely as an undesirable consequence of vascular and inflammatory disease. FAU - Thomas, Christopher P AU - Thomas CP AD - Department of Infection, Cardiff University, Cardiff CF14 4XN, United Kingdom. FAU - Morgan, Lloyd T AU - Morgan LT FAU - Maskrey, Benjamin H AU - Maskrey BH FAU - Murphy, Robert C AU - Murphy RC FAU - Kuhn, Hartmut AU - Kuhn H FAU - Hazen, Stanley L AU - Hazen SL FAU - Goodall, Alison H AU - Goodall AH FAU - Hamali, Hassan A AU - Hamali HA FAU - Collins, Peter W AU - Collins PW FAU - O'Donnell, Valerie B AU - O'Donnell VB LA - eng GR - U54 GM069338/GM/NIGMS NIH HHS/United States GR - WT_/Wellcome Trust/United Kingdom GR - P01 HL087018-020001/HL/NHLBI NIH HHS/United States GR - GM069338/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20100108 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Esters) RN - 0 (Phosphatidylcholines) RN - 0 (Phosphatidylethanolamines) RN - 59985-28-3 (12-Hydroxy-5,8,10,14-eicosatetraenoic Acid) RN - 9035-58-9 (Thromboplastin) RN - EC 1.13.11.31 (Arachidonate 12-Lipoxygenase) RN - EC 3.4.21.5 (Thrombin) SB - IM MH - *12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/chemistry/metabolism MH - Animals MH - Arachidonate 12-Lipoxygenase/metabolism MH - Blood Platelets/*metabolism MH - Esters/*chemistry/metabolism MH - Humans MH - Molecular Structure MH - Phosphatidylcholines/chemistry/*metabolism MH - Phosphatidylethanolamines/chemistry/*metabolism MH - Signal Transduction/physiology MH - Thrombin/*metabolism MH - Thromboplastin/*metabolism PMC - PMC2844139 EDAT- 2010/01/12 06:00 MHDA- 2010/04/30 06:00 PMCR- 2010/01/08 CRDT- 2010/01/12 06:00 PHST- 2010/01/12 06:00 [entrez] PHST- 2010/01/12 06:00 [pubmed] PHST- 2010/04/30 06:00 [medline] PHST- 2010/01/08 00:00 [pmc-release] AID - S0021-9258(19)58678-1 [pii] AID - M109.078428 [pii] AID - 10.1074/jbc.M109.078428 [doi] PST - ppublish SO - J Biol Chem. 2010 Mar 5;285(10):6891-903. doi: 10.1074/jbc.M109.078428. Epub 2010 Jan 8.